CARLY UNGER: Open Payments
NPI 1710665591 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 72 payments from 29 companies in 2025. Trend: 2023 $163 · 2024 $1,605 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 18 | $322 |
| ABBVIE INC. | 8 | $136 |
| Novartis Pharmaceuticals Corporation | 7 | $128 |
| Janssen Biotech, Inc. | 5 | $97 |
| PFIZER INC. | 4 | $69 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| SOBI, INC | 2 | $42 |
| TAIHO ONCOLOGY, INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Geron Corporation | 2 | $34 |
Products named: Enhertu, KISQALI, ELAHERE, DATROWAY, RYBREVANT, XTANDI, KEYTRUDA, LUTATHERA.
Industry payments across ND — which companies pay providers there.
